FOX 5 DC on MSN
IRS July 10 refund deadline: Millions may qualify for COVID-era relief, what you need to know
Tens of millions of taxpayers may qualify for refunds or penalty and interest abatements tied to Internal Revenue Service ...
May 21 (Reuters) - Moderna (MRNA.O), opens new tab said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine candidate to wait for efficacy data from ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Moderna's decision to withdraw ...
Manufacturing is underway and doses of Moderna's Spikevax 2024-2025 formula will be ready to ship as early as August, pending regulatory approval The most common solicited local adverse event for ...
CLAIM: A COVID-19 test patent application is dated 2020 but was actually filed in 2015. THE FACTS: The patent application, for a system to determine if someone has a viral infection such as COVID-19, ...
Moderna Inc. said it has “voluntarily” withdrawn its application for regulatory approval for its combination Covid and flu shot for people 50 and over, a setback for the company. The biotech company ...
Moderna has withdrawn its pending application for a combination vaccine for both the flu and Covid-19, saying it will resubmit later this year once it has more data. The maker of the Spikevax Covid-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results